{"SPADE_N_07216": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07216", "Peptide Name": "AgNP-TAT", "Source": "Protein derived", "Family": "", "Gene": "Not found", "Sequence": "CGGGYGRKKRRQRRR", "Sequence Length": 15, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C73H132N36O18S", "Mass": 1834.12, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -2.58, "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "TAT-modified nanosilver for combating multidrug-resistant cancer.", "Pubmed ID": "22682937", "Reference": "Biomaterials. 2012 Sep;33(26)6155-61.", "Author": "Liu J, Zhao Y, Guo Q, Wang Z, Wang H, Yang Y, Huang Y.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22682937"}], "Frequent Amino Acids": "RGK", "Absent Amino Acids": "ADEFHILMNOPSTUVW", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 1, "Polar Residues": 11, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07214", "Similarity": 1.0, "Sequence": "GCGGGYGRKKRRQRRR"}, {"SPADE_ID": "SPADE_N_07258", "Similarity": 1.0, "Sequence": "RKKRRQRRRGGG"}, {"SPADE_ID": "SPADE_N_07259", "Similarity": 1.0, "Sequence": "RKKRRQRRRGGGKLLKLLLKLLLKLLK"}]}}}